NeoPhotonics (NPTN): Raising PT On China Purchase Orders - Needham

Needham & Company analyst, Alex Henderson, reiterated his Strong Buy rating on NeoPhotonics (NYSE: NPTN) and increased his price target to $22 from $20. Neo thinks it can post 25% plus top line growth in CY17-CY19. The analyst sees expanding GMs and substantial OPEX leverage. Based on upside to top-line, GMs and OPEX leverage the analyst sees as much as $0.30 upside to CY17 estimates.

China Mobile “Phase 12” RFPs are out and point to a 30-60% increase over CY16. The analyst believes RFPs are hard evidence of the next round of systems orders providing scale and timing information and sharply reduces the risk to the optical “Super Cycle” thesis while extending the visibility out through CY17.

For an analyst ratings summary and ratings history on NeoPhotonics click here. For more ratings news on NeoPhotonics click here.

Shares of NeoPhotonics closed at $16.48 yesterday.

You May Also Be Interested In

• Kepler Cheuvreux Upgrades Entain PLC (ENT:LN) (GMVHF) to Buy
• BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $90; Piper Sandler: 'Remain Buyers'
• Aon Corp (AON) PT Lowered to $360 at BMO Capital